Literature DB >> 32381428

Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy.

Raffaele Gianotti1, Pietro Zerbi2, Roni P Dodiuk-Gad3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32381428      PMCID: PMC7190511          DOI: 10.1016/j.jdermsci.2020.04.007

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


× No keyword cloud information.
The current novel coronavirus (SARS-CoV-2) infection is rapidly spreading worldwide. The dissemination of the virus has been particularly severe in the Northern part of Italy (Lombardia region). Currently, we had the opportunity to study the cutaneous histopathological features of eight COVID-19 patients in different stages and with several degrees of disease. The histopathology of the skin specimens suggested a broad spectrum of cutaneous features that can all be linked to the COVID-19 interplay with the skin. Interestingly, we observed two COVID-19 patients who encountered only fever, sore throat, and cough a sudden diffuse maculopapular eruption involving only the trunk, clinically suggestive for Grover disease (Fig. 1 F). Histopathology showed, in addition to the classic dyskeratotic cells, ballooning multinucleated cells and sparse necrotic keratinocytes with lymphocytic satellitosis (Fig. 2 A–D). These overlapping features mimicking a viral infection and Grover disease have already been described in patients with simultaneous Grover and Kaposi’s varicelliform eruption [2,3]. At the time of the onset of their cutaneous eruption, these patients were also on no new drug treatment. The others developed cutaneous lesions during hospitalization and were treated with levofloxacin and hydroxychloroquine that are not recognized to cause a diffuse lymphocytic vasculitis with microthrombi formation.
Fig. 1

A) Diffuse maculo-papulo-vesicular rash. Hemorragic dot-like area are due to extravasated erytrhocytes. B) Sligthly papular erythematous exanthema of the trunk. C) Diffuse macular livedoid hemorrhagic lesions in a patient with CID like histopathological feature. (D &E) Initial resolution of the lesions after therapy. (F) Erythematous papular eruption with crusted and erosive lesions mimicking Grover disease.

Fig. 2

A) Parakeratosis, acanthosis, dyskeratotic keratinocytes and small acantholytic cleft (arrow). B) Dyskeratotic keratinocytes in the upper part of the epidermis. Necrotic keratinocytes (arrow). Inset, Necrotic keratinocytes with lymphocytes satellitosis (arrow). C Necrotic keratinocytes (arrow) and more prominent acantholytic cleft. D) Necrotic keratinocytes (double arrows) and pseudo-herpetic features (arrow).

A) Diffuse maculo-papulo-vesicular rash. Hemorragic dot-like area are due to extravasated erytrhocytes. B) Sligthly papular erythematous exanthema of the trunk. C) Diffuse macular livedoid hemorrhagic lesions in a patient with CID like histopathological feature. (D &E) Initial resolution of the lesions after therapy. (F) Erythematous papular eruption with crusted and erosive lesions mimicking Grover disease. A) Parakeratosis, acanthosis, dyskeratotic keratinocytes and small acantholytic cleft (arrow). B) Dyskeratotic keratinocytes in the upper part of the epidermis. Necrotic keratinocytes (arrow). Inset, Necrotic keratinocytes with lymphocytes satellitosis (arrow). C Necrotic keratinocytes (arrow) and more prominent acantholytic cleft. D) Necrotic keratinocytes (double arrows) and pseudo-herpetic features (arrow). An hospitalized patient was biopsied at early stage of a exanthema involving the trunk and limbs. The first punch biopsy showed in the upper dermis diffuse telangiectatic small blood vessels with no other peculiar features (Fig. 3 A). In a second punch nests of Langerhans cells within the epidermis was the unique clue in this stage (Fig. 3B). When purpuric maculo-papulo-vesicular rash was developed (Fig. 1A), histological findings showed a perivascular spongiotic dermatitis with exocytosis along with a large nest of Langerhans cells and a dense perivascular lymphocytic infiltration eosinophilic rich around the swollen blood vessels with extravasated erythrocytes (Fig. 3C).
Fig. 3

A) Initial phase of the exantematous rash. Merely teleangectatic blood vessels (arrows) B) Exanthematous rash biopsied three days after the onset. A small nest of Langerhans cell within the epidermis (arrow). Mild perivascular lymphocytic infiltration in the superficial dermis. C) A papulo-vesicular lesion. Spongiosis, a large intraepidermal nest of Langerhans cell. D) Maculo-papular exanthema. E) Haemorragic diffuse exanthematous rash. A small thrombus in a capillary vessel (arrow).

A) Initial phase of the exantematous rash. Merely teleangectatic blood vessels (arrows) B) Exanthematous rash biopsied three days after the onset. A small nest of Langerhans cell within the epidermis (arrow). Mild perivascular lymphocytic infiltration in the superficial dermis. C) A papulo-vesicular lesion. Spongiosis, a large intraepidermal nest of Langerhans cell. D) Maculo-papular exanthema. E) Haemorragic diffuse exanthematous rash. A small thrombus in a capillary vessel (arrow). Specimen from a hospitalized old man with papular erythematous exanthema involving trunk (Fig. 1B) showed edematous dermis with many eosinophils. Cuffs of lymphocytes around blood vessels in a lymphocytic vasculitis histopathological pattern were observed (Fig. 3D). Hospitalized patient in ICU had a severe macular haemorrhagic eruption (Fig. 1C–E), which corresponds to intravascular microthrombi in the small dermal vessels (Fig. 3E). Autopsy records from SARS-CoV-2 infected patients reported this element in the lung and skin microvessels [1]. Among skin pathologies in which a virus is implicated, we can see various types of manifestations in the cutaneous district involved. Frequently, it is merely an exanthema indicating a hematogenous spreading of the virus through the cutaneous vascular system. The next step could create activation of the immune system with mobilization of lymphocytes and Langerhans cells patrolling that run through the skin-lymph node path. If the virus swarm induces the creation of immune complexes, this can lead CD4 + T helper lymphocytes to produce cytokines, like IL-1, IFN-γ, and TNF-α, and to recruit eosinophils, CD8+ cytotoxic T cells, B cells and natural killer (NK) cells leading a lymphocytic thrombophilic arteritis [4]. Sepsis or severe viral infections could activate the cytokine cascade inducing a CID phenomenon [5]. Just like we observed in the skin and in the lung and kidneys of COVID + patients. However, there are underhanded viral attacks that probably induce a modification in the structure of the keratinocyte, which is destroyed by the cytotoxic lymphocytes, almost resembling the well- known ancient trick of the "Trojan horse." In lichen striatus, a viral alteration of the keratinocyte clones along the Blaschko's lines has been hypothesized [[6], [7], [8]]. In fact, in its classic form, it can be observed histologically a band like dermatitis with lymphocyte satellitosis destroying the keratinocytes. Also, here we have the presence of Langerhans nests. Ultimately, the HSV is suspected of provoking stimulation of immunopathological mechanisms in erythema multiforme. The herpes virus could play a role in autoimmune cross-reactivity [9], triggering the keratinocyte that activates IL-1, IFN-γ, and TNF-α, recruiting cytotoxic and NK cells that target the keratinocytes itself. Histopathological examination of lung biopsy of COVID + pneumonia indicates a severe damage of the alveolar epithelial cell floating in the alveolar space just like in bullous severe erythema multiforme in which ballooning keratinocytes detach from the spinous layer [10]. In 1955, Ferdinando Gianotti, father of first author, published as a single author, the first observation of unusual dermatitis, which later became known as “Gianotti-Crosti disease” [11]. Langerhans’ nests were present along with a scattered perivascular and lymphocytic infiltrate that was slightly more epidermotropic than the recently reviewed cases of the two patients with a rash. We think that different clinical features of skin eruption in patients with COVID infection reflect a full spectrum of viral interaction with the skin. Further histopathological studies and PCR investigation on skin biopsies are necessary to clarify the close relationship between skin and SARS-CoV-2 infection.
  11 in total

Review 1.  Gianotti-Crosti syndrome.

Authors:  Oliver Brandt; Dietrich Abeck; Raffaele Gianotti; Walter Burgdorf
Journal:  J Am Acad Dermatol       Date:  2005-12-02       Impact factor: 11.527

2.  Lichen striatus (blaschkitis) following varicella infection.

Authors:  C Hafner; M Landthaler; T Vogt
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-11       Impact factor: 6.166

Review 3.  Pathogenesis and diagnosis of disseminated intravascular coagulation.

Authors:  M Levi
Journal:  Int J Lab Hematol       Date:  2018-05       Impact factor: 2.877

4.  Lichen striatus--a chameleon: an histopathological and immunohistological study of forty-one cases.

Authors:  R Gianotti; L Restano; R Grimalt; E Berti; E Alessi; R Caputo
Journal:  J Cutan Pathol       Date:  1995-02       Impact factor: 1.587

5.  Clinico-Pathological Study of 4 Cases of Pseudoherpetic Grover Disease: The Same as Vesicular Grover Disease.

Authors:  Tania M Capusan; María Herrero-Moyano; Javier Fraga; Mar Llamas-Velasco
Journal:  Am J Dermatopathol       Date:  2018-06       Impact factor: 1.533

Review 6.  Kaposi's varicelliform eruption in a patient with Grover's disease.

Authors:  Meredith Klein Kosann; Joshua P Fogelman; Roy L Stern
Journal:  J Am Acad Dermatol       Date:  2003-11       Impact factor: 11.527

7.  Lymphocytic thrombophilic arteritis: a newly described medium-sized vessel arteritis of the skin.

Authors:  Joyce Siong-See Lee; Steven Kossard; Michael A McGrath
Journal:  Arch Dermatol       Date:  2008-09

8.  [A pathological report of three COVID-19 cases by minimal invasive autopsies].

Authors:  X H Yao; T Y Li; Z C He; Y F Ping; H W Liu; S C Yu; H M Mou; L H Wang; H R Zhang; W J Fu; T Luo; F Liu; Q N Guo; C Chen; H L Xiao; H T Guo; S Lin; D F Xiang; Y Shi; G Q Pan; Q R Li; X Huang; Y Cui; X Z Liu; W Tang; P F Pan; X Q Huang; Y Q Ding; X W Bian
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2020-05-08

Review 9.  From HSV infection to erythema multiforme through autoimmune crossreactivity.

Authors:  Alberta Lucchese
Journal:  Autoimmun Rev       Date:  2018-04-07       Impact factor: 9.754

10.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

View more
  31 in total

1.  Histopathological analysis of soft tissue changes in gingival biopsied specimen from patients with underlying corona virus disease associated mucormycosis (CAM).

Authors:  D Pandiar; P Ramani; R-P Krishnan; D Y
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-05-01

Review 2.  Oral Mucosa, Saliva, and COVID-19 Infection in Oral Health Care.

Authors:  Devi Sewvandini Atukorallaya; Ravindra K Ratnayake
Journal:  Front Med (Lausanne)       Date:  2021-04-22

3.  Inflammatory Skin Lesions in Three SARS-CoV-2 Swab-Negative Adolescents: A Possible COVID-19 Sneaky Manifestation?

Authors:  Giuseppe Ingravallo; Francesco Mazzotta; Leonardo Resta; Sara Sablone; Gerardo Cazzato; Antonietta Cimmino; Roberta Rossi; Anna Colagrande; Beniamino Ferrante; Teresa Troccoli; Ernesto Bonifazi
Journal:  Pediatr Rep       Date:  2021-04-09

4.  A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Milad Dodangeh; Afsaneh Sadeghzadeh-Bazargan; Elham Behrangi; Samaneh Mozafarpoor; Azadeh Goodarzi
Journal:  Exp Dermatol       Date:  2021-05-24       Impact factor: 4.511

5.  Histopathological Study of a Broad Spectrum of Skin Dermatoses in Patients Affected or Highly Suspected of Infection by COVID-19 in the Northern Part of Italy: Analysis of the Many Faces of the Viral-Induced Skin Diseases in Previous and New Reported Cases.

Authors:  Raffaele Gianotti; Sebastiano Recalcati; Fabrizio Fantini; Cristina Riva; Mario Milani; Emanuele Dainese; Francesca Boggio
Journal:  Am J Dermatopathol       Date:  2020-08       Impact factor: 1.533

6.  Similarities in Cutaneous Histopathological Patterns between COVID-19-positive and COVID-19 High-risk Patients with Skin Dermatosis.

Authors:  Raffaele Gianotti; Antonella Coggi; Francesca Boggio; Giovanni Fellegara
Journal:  Acta Derm Venereol       Date:  2020-08-19       Impact factor: 3.875

Review 7.  Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.

Authors:  Niloufar Najar Nobari; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

8.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

9.  Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India.

Authors:  Ashish Dalal; Deepak Jakhar; Vishal Agarwal; Ravi Beniwal
Journal:  Dermatol Ther       Date:  2020-07-06       Impact factor: 3.858

10.  Clinical and histopathological findings of cutaneous manifestations of COVID-19 patients.

Authors:  Maria Girlane Sousa Albuquerque Brandão; Lívia Moreira Barros; Jamilly de Aquino Mendonça; Aline Ramalho de Oliveira; Thiago Moura de Araújo; Vivian Saraiva Veras
Journal:  Dermatol Ther       Date:  2020-09-28       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.